Synaptogenix Inc (SNPX)

[Cyosol]

The way I see it, it looks like the FDA will let them skip Phase 1 for all new indications (I think Dr. Ryan also mentioned this as being a unique situation for him), since there are already so many studies confirming Bryostatin is safe at these low doses.

It's starting to look like the 20 dose could singlehandedly treat several different diseases alone since the consequences of the different diseases and the effect of the drug looks to be the same across indications (i.e. brain damage and brain repair).

In a way, you could call this a universal brain repair drug if the new trials all show the same synaptogenesis, or "rewiring of the brain".